Barnet, M. B., Jackson, K. J. L., Masle-Farquhar, E., Russell, A., Burnett, D. L., Chye, A., Jara, C. J., Faulks, M., Mawson, A., Peters, T. J., Brink, R., Wright, K., Allen, I., Junankar, S., Davis, I. D., Heller, G., Khan, Z., Bruce, J., Yang, C., Prokopec, S., Pugh, T., Behren, A., Hold, G. L., Zhang, F., Cooper, W. A., Gao, B., Nagrial, A., Joshua, A. M., John, T., Peters, G., Hui, R., Boyer, M., Blinman, P. L., Kao, S. C., Cebon, J., Goodnow, C. C. (2025). Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2314258122